S
TRAW icon

SignatureFD’s Traws Pharma TRAW Stock Holding History

SignatureFD’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-16
Closed -$472 – 3326
2023
Q2 		$472 Hold
16
– – ﹤0.01% 3075
2023
Q1 		$292 Hold
16
– – ﹤0.01% 3154
2022
Q4 		$258 Hold
16
– – ﹤0.01% 3174
2022
Q3 		$0 Hold
16
– – ﹤0.01% 3393
2022
Q2 		$1K Hold
16
– – ﹤0.01% 3041
2022
Q1 		$1K Hold
16
– – ﹤0.01% 3082
2021
Q4 		$1K Buy
+16
New +$1.29K ﹤0.01% 3024

Other funds holding TRAW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return

SignatureFD's TRAW Position: Q3 2023 in Review

SignatureFD sold out of Traws Pharma (TRAW) in Q3 2023, closing a stake of 16 shares — an estimated $472 sold.

SignatureFD first reported a position in TRAW in Q4 2021 and held it in 7 quarters. The position peaked at $1K in Q2 2022. 27 funds tracked by Wall St. Rank hold TRAW as of Q3 2023.

  • SignatureFD reported no remaining Traws Pharma position as of Q3 2023 after selling out during the quarter.
  • SignatureFD sold 16 Traws Pharma shares in Q3 2023, an estimated $472.
  • SignatureFD first reported a position in Traws Pharma in Q4 2021 and held it in 7 quarters.
  • SignatureFD's Traws Pharma position peaked at $1K in Q2 2022.
  • 27 funds tracked by Wall St. Rank held Traws Pharma as of Q3 2023.

Based on SignatureFD's 13F filing for Q3 2023, filed 3 Nov 2023.